
Opthea Ltd (OPT)
US$ 3.07-3.15%
Price Chart
Key Statistics
Market Cap
$ 524.82M
P/E Ratio
0.00
Revenue (TTM)
$ 208.86K
Volume
15.16K
52W High
$ 6.30
52W Low
$ 1.79
Dividend Yield
0.00%
Beta
1.59
Technicals
50-Day MA
4.0165
200-Day MA
3.6124
52 Week High
6.3
52 Week Low
1.79
About OPT
Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States. Its development activities are based on the intellect.
Employees
33
Headquarters
South Yarra, VIC
CEO
Dr. Frederic Guerard M.S., Pharm.D.
Latest News
STEM OPT Denial: Same Course, Different Results - M9.news
Yesterday • Google News
Injury-plagued Girlz opt for versatility against US - Jamaica Gleaner
18 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg